Physicians of Excellence, Orange County Medical Association

2015

Neurology — SuperDoctors® edition of Los Angeles magazine

Southern California Rising Star™

Ruth L. Kirschstein National Research Service Award

American Federation of Aging Research Glenn/AFAR Fellowship

American Board of Psychiatry and Neurology

Society of Neuro-Oncology

American Society of Clinical Oncology

American Academy of Neurology

Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neurons

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

A Novel Rat Ovarian Cancer Model Developed to Examine Chemotherapy-Related Cognitive Impairments

PDCT-17 (LTBK-11). PNOC007: H3.3K27M Specific Peptide Vaccine Combined With Poly-ICLC for the Treatment of Newly Diagnosed HLA-A2+ H3.3K27M Midline Gliomas

Management of low-grade glioma: a systematic review and meta-analysis

In 1965, the University of California, Irvine was founded with a mission to catalyze the community and enhance lives through rigorous academics, cutting-edge research, and dedicated public service. Today, we draw on the unyielding spirit of our pioneering faculty, staff and students who arrived on campus with a dream to inspire change and generate new ideas. We believe that true progress is made when different perspectives come together to advance our understanding of the world around us. And we enlighten our communities and point the way to a better future. At UCI, we shine brighter.

UC Irvine

Dr. Daniela A. Bota is a UCI Health neuro-oncologist who specializes in the treatment of primary and metastatic brain and spinal cord tumors, as well as in the neurological complications of cancers.

Bota is co-director of the UCI Health Comprehensive Brain Tumor Program and is a lead investigator on several clinical trials, including novel treatments using brain tumor vaccines and the use of electrical fields to inhibit the growth of gliomas.

Clinical Trials

Neuro-Oncology

Brain Cancer

Neurology

Brain Tumors

UCI Faculty Profile

UCI Health Profile

Google Scholar Citations

ResearchGate Citations

Novel approaches to malignant brain tumor treatment aim to overcome familiar challenges

A Cancer-Quashing Microbe Emerges from the Deep

UCI Health Research Leads Fight Against COVID-19

Trump brags that he’s helping patients access medical ‘miracles.’ He isn’t.

Scientists develop a blood test to predict how long patients with the aggressive brain cancer that killed John McCain will live - and it could lead to custom treatments

Glioblastoma patient's tumor no longer measurable thanks to promising clinical trial

Brain Cancer Patient Is First to Get Untested Treatment Under Trump-Backed Law

The Mechanisms of Chemotherapy Induced Cognitive Defects

Associate Dean of Clinical Research and Associate Professor of Neurology

Watch the full lecture here: https://youtu.be/l4KkZSKHaAM

Daniela Bota Intro - Hope vs. Hype: Anatomy of a Clinical Trial

Treating the Cancer Treatment? Radiation Biology and Stem Cells
Presented by Munjai Acharya, PhD and Daniela Bota, MD, PhD
February 25, 2020

Daniela Bota Intro - Treating the Cancer Treatment? Radiation Biology and Stem Cells

Daniela Bota, MD, PhD, medical director, Neuro-Oncology Program, associate professor, Neurology School of Medicine, UC Irvine Health, discusses marizomib for the treatment of patients with glioma.

Dr. Bota on Marizomib in Patients with Glioma

Select Inquiry Type